ÂÜÀòÂÒÂ×

Eric has an extensive background in the biotech and healthcare investment industry, with experience in asset acquisition, business development, and corporate development. He has a strong track record of working with various companies and organizations in the field, including founding and directing business development at Stingray Therapeutics. Eric currently serves as a Principal at TCG Labs-Soleil, where he focuses on therapeutics investments. With a Bachelor's degree in Biological Engineering from MIT and a Ph.D. in Bioengineering from Rice University, Eric brings a wealth of knowledge and experience to his role in the industry.